Umbilical cord blood cell therapy may reduce signs and symptoms of Alzheimer... ( Tampa FL (March 26 2008) Targeted i...)

Umbilical cord blood cell therapy may reduce signs and symptoms of Alzheimer's disease

Date:3/26/2008

Tampa, FL (March 26, 2008) Targeted immune suppression using human umbilical cord blood cells may improve the pathology associated with Alzheimers disease, a new study in a mouse model of this currently untreatable neurodegenerative condition reports. The study, led by researchers at the University of South Florida, is published online in the peer-reviewed journal Stem Cells and Development (www.liebertpub.com/scd).

Following a series of low-dose infusions of human umbilical cord blood cells into mice with Alzheimers-like disease, the amount of amyloid- and -amyloid plaques -- hallmarks of Alzheimers pathology in the brain -- was reduced 62 percent. Amyloid- induces an inflammatory response in the brain associated with the interaction of CD40 and CD40L, two pro-inflammatory molecules. Researchers also reported an astonishing 86-percent improvement in cerebral amyloid angiopathy (CAA), another hallmark of Alzheimers disease. CAA compromises the integrity of the blood-brain barrier, disrupting normal trafficking of various molecules and cells from and to the brain and is believed to be the main culprit for the brain inflammation observed in Alzheimers.

Human umbilical cord blood cell therapy appeared to suppress CD40-CD40L activity, suggesting that this therapeutic approach offers the potential to target the pathogenic inflammatory response that contributes to Alzheimers disease and other degenerative conditions.

Jun Tan, PhD, MD, and colleagues from USF (Tampa), Yale University (New Haven, CT), Cedars-Sinai Medical Center (Los Angeles, CA), Saneron CCEL Therapeutics (Tampa, FL), and Saitama Medical School (Japan), concluded that human umbilical cord blood cell-induced disruption of the CD40-CD40L interaction may alleviate the key pathologic changes in the brain associated with Alzheimers disease.

It has been well documented that altered immune functioning, characterized by the p
'/>"/>

Contact: Anne DeLotto Baier
abaier@health.usf.edu
813-974-3300
University of South Florida Health
Source:Eurekalert

0

GOOD

Page: 1 2
Related biology news :

1. Umbilical cord blood cell therapy in an animal model of Alzheimers disease
2. Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice
3. Diabetes makes it hard for blood vessels to relax
4. Weill Cornell team discovers how brains own tPA helps regulate blood flow to neurons
5. High blood pressure in older adults traced to genes effects in blood vessels
6. Eltrombopag effective for hepatitis C patients with low blood-platelet counts
7. MIT works toward engineered blood vessels
8. Blood pressure drug telmisartan shows powerful activity against stroke
9. Protein controls blood vessel formation, offers new drug target
10. Looking through the eyes of a mouse, scientists monitor circulating cells in its bloodstream
11. Study of malaria parasite in patient blood finds distinct physiological states

Post Your Comments:

(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...

(Date:5/17/2013)... residents of all ages will celebrate the science ... on our daily lives during the inaugural Atlanta ... and educators from local museums, corporations, K-12 schools ... 40 different events for children and adults at ... http://atlantasciencefestival.org . , The annual Atlanta Science ...

(Date:5/17/2013)... Efficient and Sustainable Global Logistics Operations) is aiming to ... efficiency of intermodal loading systems and the boosting of ... European organisations with experience in the logistics sector and ... 17,000,000 and a duration of three and a half ... the semantic components and ontologies shared by the users, ...

Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2 First Atlanta Science Festival set for 2014 2 New logistics services that will cut energy consumption and CO2 emissions 2

[0] New gut microbiome research to explore red meat -- colorectal cancer pathway [0] First Atlanta Science Festival set for 2014 [0] New logistics services that will cut energy consumption and CO2 emissions

... New research suggests a higher-protein, lower-carbohydrate energy-restricted diet has ... fat and increasing lean muscle, particularly when the proteins ... the September issue of the Journal of Nutrition, ... otherwise healthy, premenopausal women. Each consumed either low, ...

... Lithuania, Aug. 29, 2011 Neurotechnology ... technologies, today announced the availability of SentiSight 3.0 ... recognition. This latest version adds shape-based recognition and offers ... SentiSight 2.1. It also includes enhanced tracking of fast ...

... which can stop the formation of long protein strands, ... kidney dialysis patients has been identified by researchers at ... to new methods to identify drugs to prevent, treat ... amyloid fibrils play a part, including Alzheimer,s, Parkinson,s and ...

Cached Biology News:Foods rich in protein, dairy products help dieters preserve muscle and lose belly fat: study 2 SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 2 SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 3 SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 4 Research offers new way to target shape-shifting proteins 2

Foods rich in protein, dairy products help dieters preserve muscle and lose belly fat: study SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology Research offers new way to target shape-shifting proteins

(Date:5/20/2013)... 2013 , Collaboration with ... (ARS) in treatment of mastitis , ... Trials to begin in the second half 2013 ... Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will ... Research Service (ARS) to develop and trial products targeting ...

(Date:5/20/2013)... ANGELES , May 20, 2013 Today, ... San Francisco , James McGough ... Clinical Psychiatry at the Semel Institute for Neuroscience and ... of Medicine at the University of California Los ... both Child and Adolescent Psychopharmacology and ADHD at UCLA, ...

(Date:5/20/2013)... With bed bugs' presence come problems in various ... need to be eliminated, one must make sure that the ... And so to help bed bug sufferers get that done, ... bed bugs without using harmful pesticides. In it, the ... Bed Bug Bully. , According to My Cleaning Products, contrary ...

(Date:5/20/2013)... May 20, 2013 Rhythm announced today the ... RM-131, the company,s novel ghrelin agonist for the treatment ... trial demonstrated that RM-131 significantly accelerates early gastric emptying ... diabetic patients with diabetic gastroparesis. The findings were presented ... Orlando and recently published in ...

Breaking Biology Technology:Phosphagenics Signs Research Agreement with the Agricultural Research Service 2 Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2 Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3 Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4 Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5 New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2 Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 2 Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 3

[0] Phosphagenics Signs Research Agreement with the Agricultural Research Service [0] Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS)[0] New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products [0] Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes

... by 45.7%, Profit Attributable to Shareholders ... 14 /Xinhua-PRNewswire/ -- Fufeng Group Limited,("Fufeng" or "the ... corn-based biochemical products in China, today announces,its interim ... 2008., During the period under review, driven ...

... Aug. 14 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... the,discovery, development and commercialization of novel drugs in ... today,announced its financial results for the second quarter ... ), The net loss for the three ...

... Derma Sciences, Inc.,(OTC Bulletin Board: DSCI), a provider ... second quarter and first six months ended,June 30, 2008. ... and,distribution capacity provided by the Company,s new First Aid ... flagship product, MEDIHONEY(R). For,the second quarter in 2008, the ...

Fufeng Announces 2008 Interim Results With Strong Sign of Recovery Advanced Life Sciences Announces Second Quarter 2008 Financial Results Derma Sciences Reports Second Quarter 2008 Results

Rabbit polyclonal to VEZT ( Abpromise for all tested applications). Antigen: Full length human VEZT conjugated to GST Entrez Gene ID: 55591 Swiss Protein ID: Q9HBM0...

WTAP Antibody...

Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...

...

Biology Products:

Rabbit Anti-Human VEZT Polyclonal Antibody, Unconjugated from Abcam Chicken Anti-WTAP Polyclonal Antibody, Unconjugated from ProSci, Inc Mouse Anti-Factor V Heavy Chain Monoclonal Antibody, Unconjugated from GeneTex LC/MSD TOF from Agilent Technologies